Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.
Altered T-cell subset distribution in the viral reservoir in HIV-1-infected individuals with extremely low proviral DNA.
Motivations, barriers and experiences of participants in an HIV reservoir trial.
Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy.
Erratum for Puertas et al., "VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies".
Launching a multidisciplinary European collaboration towards a cure for HIV: The EU2Cure Consortium.
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies.
An HLA-I signature favouring KIR-educated Natural Killer cells mediates immune control of HIV in children and contrasts with the HLA-B-restricted CD8+ T-cell-mediated immune control in adults.
Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM).
Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.